ATE463508T1 - Reagentien und verfahren zur erkennung von erkrankungen der brust - Google Patents

Reagentien und verfahren zur erkennung von erkrankungen der brust

Info

Publication number
ATE463508T1
ATE463508T1 AT00903373T AT00903373T ATE463508T1 AT E463508 T1 ATE463508 T1 AT E463508T1 AT 00903373 T AT00903373 T AT 00903373T AT 00903373 T AT00903373 T AT 00903373T AT E463508 T1 ATE463508 T1 AT E463508T1
Authority
AT
Austria
Prior art keywords
breast
diseases
reagents
methods
useful
Prior art date
Application number
AT00903373T
Other languages
English (en)
Inventor
Patricia Billing-Medel
Maurice Cohen
Tracey Colpitts
Paula Friedman
Julian Gordon
Edward Granados
Steven Hodges
Michael Klass
Jon Kratochvil
John Russell
Stephen Stroupe
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE463508T1 publication Critical patent/ATE463508T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3015Breast
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/30Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT00903373T 1999-01-21 2000-01-21 Reagentien und verfahren zur erkennung von erkrankungen der brust ATE463508T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23471699A 1999-01-21 1999-01-21
PCT/US2000/001452 WO2000043420A1 (en) 1999-01-21 2000-01-21 Reagents and methods useful for detecting diseases of the breast

Publications (1)

Publication Number Publication Date
ATE463508T1 true ATE463508T1 (de) 2010-04-15

Family

ID=22882506

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00903373T ATE463508T1 (de) 1999-01-21 2000-01-21 Reagentien und verfahren zur erkennung von erkrankungen der brust

Country Status (8)

Country Link
US (1) US20060154291A1 (de)
EP (1) EP1144449B1 (de)
JP (1) JP2002540761A (de)
AT (1) ATE463508T1 (de)
CA (1) CA2358800C (de)
DE (1) DE60044119D1 (de)
ES (1) ES2343103T3 (de)
WO (1) WO2000043420A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6680197B2 (en) 1998-12-28 2004-01-20 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6579973B1 (en) 1998-12-28 2003-06-17 Corixa Corporation Compositions for the treatment and diagnosis of breast cancer and methods for their use
US6586572B2 (en) * 1998-12-28 2003-07-01 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6958361B2 (en) 1998-12-28 2005-10-25 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6518237B1 (en) 1998-12-28 2003-02-11 Corixa Corporation Compositions for treatment and diagnosis of breast cancer and methods for their use
US6528054B1 (en) 1998-12-28 2003-03-04 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6969518B2 (en) 1998-12-28 2005-11-29 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US7598226B2 (en) 1998-12-28 2009-10-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6844325B2 (en) 1998-12-28 2005-01-18 Corixa Corporation Compositions for the treatment and diagnosis of breast cancer and methods for their use
US6573368B2 (en) 1998-12-28 2003-06-03 Corixa Corporation Compositions for the treatment and diagnosis of breast cancer and methods for their use
US6590076B1 (en) 1999-04-02 2003-07-08 Corixa Corporation Compositions for the treatment and diagnosis of breast cancer and methods for their use
EP1248800A2 (de) 1999-11-30 2002-10-16 Corixa Corporation Kompositionen und methoden zur therapie und diagnose von brustkrebs
WO2004092212A2 (en) * 2003-04-15 2004-10-28 Sanofi Pasteur Limited Tumor antigens bfa5 for prevention and/or treatment of cancer
US8207314B2 (en) * 2003-05-16 2012-06-26 Sanofi Pasteur Limited Tumor antigens for prevention and/or treatment of cancer
WO2007137174A2 (en) * 2006-05-18 2007-11-29 The Ohio State University Research Foundation Compositions and methods for the detection of vulnerable plaque

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2804445A1 (de) 1978-02-02 1979-08-09 Studiengesellschaft Kohle Mbh Verfahren zur herstellung von magnesiumhydriden
US5618695A (en) * 1995-06-07 1997-04-08 Mayo Foundation For Medical Education And Research DNA encoding HEM-1, a gene expressed by sclerosing hemangioma cells
US5736331A (en) * 1995-07-08 1998-04-07 Schering Corporation Method for identifying nucleic acids encoding c-fos promoter activating proteins
JP4614472B2 (ja) * 1996-10-31 2011-01-19 アボット・ラボラトリーズ 乳房の疾患の検出に有用な試薬および方法
US20020018990A1 (en) * 1997-06-20 2002-02-14 Patricia A. Billing-Medel Reagents and methods useful for detecting diseases of the breast
CA2292843A1 (en) * 1997-07-07 1999-01-21 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast
CA2309756A1 (en) * 1997-11-17 1999-05-27 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast

Also Published As

Publication number Publication date
CA2358800C (en) 2015-03-17
CA2358800A1 (en) 2000-07-27
EP1144449A1 (de) 2001-10-17
EP1144449B1 (de) 2010-04-07
WO2000043420A1 (en) 2000-07-27
JP2002540761A (ja) 2002-12-03
ES2343103T3 (es) 2010-07-23
DE60044119D1 (de) 2010-05-20
US20060154291A1 (en) 2006-07-13

Similar Documents

Publication Publication Date Title
WO2000056352A3 (en) Reagents and methods useful for detecting diseases of the prostate
ATE364089T1 (de) Reagenzien und methoden zum nachweis von erkrankungen der brust
ATE463508T1 (de) Reagentien und verfahren zur erkennung von erkrankungen der brust
JP5639989B2 (ja) 診断および治療のための腫瘍関連細胞表面抗原の同定
DE60126592D1 (de) Verfahren, zusammensetzungen und kits zur identifizierung und überwachung von brustkrebs
DE69833572D1 (de) Verfahren zur bestimmung des metastasierungspotentials unter verwendung des asp1 gens
HRP20131047T1 (hr) Identifikacija antigena povezanih s tumorom za dijagnozu i lijeäśenje
ATE403001T1 (de) Antigenbindungsfragmente die spezifisch krebszellen nachweisen, nukleotide die für diese fragmente kodieren, und deren verwendung zur vorbeugung und zum nachweis von krebs
CA2395729A1 (en) Nucleic acids, proteins, and antibodies
EP1578923A4 (de) Lösliche mic-polypeptide als marker zur diagnose, prognose und behandlung von krebs sowie autoimmunkrankheiten oder -erkrankungen
ATE419516T1 (de) Monoklonale antikörper und zelloberflächenantigene zum nachweis und zur behandlung von kleinzelligem lungenkrebs (sclc)
Wu et al. Zinc finger protein 191 inhibits hepatocellular carcinoma metastasis through discs large 1‐mediated yes‐associated protein inactivation
ATE292801T1 (de) Verfahren zum screening von inhibitoren von asp2
Vadon-Le Goff et al. Identification of PCPE-2 as the endogenous specific inhibitor of human BMP-1/tolloid-like proteinases
EA200501197A1 (ru) Композиции и способы для лечения злокачественной опухоли с применением igsf9 и liv - 1
ATE449171T1 (de) Reagentia und verfahren zum nachweis von brustkrankheiten
WO2002040673A3 (en) Compositions and methods relating to lung specific genes and proteins
Moshitch-Moshkovitz et al. In vivo direct molecular imaging of early tumorigenesis and malignant progression induced by transgenic expression of GFP-Met
DK2230253T3 (da) Antistoffer mod en homolog til MDR-P-glycoproteinet på kromosom 7p15-21 og anvendelser deraf
CN112162097B (zh) Gdf1作为评估pd-1单抗治疗效果的生物标志物
WO2000041516A3 (en) Reagents and methods useful for detecting diseases of the breast
WO1999031274A3 (en) Reagents and methods useful for detecting diseases of the pancreas
WO2002004952A3 (en) Diagnostic and therapeutic methods based on the l1 adhesion molecule for ovarian and endometrial tumors
WO2005017102A3 (en) Compositions, splice variants and methods relating to ovarian specific nucleic acids and proteins
DE69939379D1 (de) Hemmstoff zur diagnose und behandlung von haemophilia a patienten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1144449

Country of ref document: EP